期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
尿基复肥造粒工艺概述
1
作者 张继亨 宋炳奇 《化肥设计》 CAS 2002年第6期27-29,共3页
介绍尿基复肥造粒工艺的特性 ,从造粒物料的粒度、液相需量。
关键词 尿基复肥 造粒工艺 团粒法 液相需量 温度 CRH分布
下载PDF
Removal of Pharmaceutically Active Compounds in Sequencing Batch Reactor
2
作者 Beata Kamifiska Koleta Majewska Anna Skwierawska Natalia Lukasik Katarzyna Koztowska-Tylingo , 《Journal of Environmental Science and Engineering(A)》 2015年第9期484-489,共6页
Biological treatment efficiency of six pharmaceutical compounds (acetazolamide, metronidazole, opipramol, piracetam, salicylamide and tinidazole) was evaluated using lab-scale Sequencing Batch Reactor (SBR). Compa... Biological treatment efficiency of six pharmaceutical compounds (acetazolamide, metronidazole, opipramol, piracetam, salicylamide and tinidazole) was evaluated using lab-scale Sequencing Batch Reactor (SBR). Comparative biological degradation processes of two types of activated sludge from municipal and pharmaceutical industry sewage treatment plants were examined. Three different organic loadings (0.05 g COD/g MLSS.d, 0.1 g COD/g MLSS.d and 0.2 g COD/g MLSS-d) and reaction time on the efficiency of Active Pharmaceutical Ingredient (API) decomposition were examined. Chemical oxygen demand, non-purgeable organic carbon as well as ammonium nitrogen contents were monitored by standard methods. Percentage of API decomposition was analysed by High Performance Liquid Chromatography (HPLC). The overall API removal efficiency was strictly dependent on the type of activated sludge origin. The main biodegradation products were identified using HPLC-MS,1H NMR and 13C NMR methods as e.g. ({4-[3-(5H-dibenzo[b,f]azepin-5-yl]piperazin-l-yl}methanamine) and (2-amino-1,3,4-thiadiazol-5-sulfonamide) for opipramol and acetazolamide respectively. 展开更多
关键词 Active pharmaceutical ingredients sequencing batch reactor biodegradation.
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部